Lois E. Shepherd

<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker et al. · New England Journal of Medicine · 2008 · 3.6K citations

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Christine Ribic, Daniel J. Sargent, Malcolm J. Moore et al. · New England Journal of Medicine · 2003 · 2.1K citations · Full text

High-frequency Microsatellite Instability, Immunology, Adjuvant Chemotherapy +16

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Kathy S. Albain, William E. Barlow, Steven Shak et al. · The Lancet Oncology · 2009 · 1.4K citations · Full text

21-Gene Recurrence Score, Breast Oncology, Medicine +8

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

Paul E. Goss, James N. Ingle, Silvana Martino et al. · JNCI Journal of the National Cancer Institute · 2005 · 1.1K citations · Full text

All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic Leukemia

Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer et al. · New England Journal of Medicine · 1997 · 1.1K citations